Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01018836 : Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
PhasePhase 1
AgesMin: 18 Years Max: N/A
Eligibility
DISEASE CHARACTERISTICS:

- Histologically confirmed solid tumor

- Has ? 2 brain metastases as demonstrated by baseline MRI

- Patients with only 1 metastasis are eligible provided the metastasis is too
large for radiosurgery and not amenable to surgical resection

- Not being considered for surgical resection

- Eligible to undergo whole-brain radiotherapy (WBRT)

PATIENT CHARACTERISTICS:

- ECOG performance status 0-2

- ANC ? 1,000/?L

- Platelet count ? 50,000/?L

- Total bilirubin ? 1.5 times upper limit of normal (ULN)

- AST/ALT ? 1.5 times ULN

- INR ? 1.5 times ULN

- Sodium normal

- Thyroid-stimulating hormone normal

- Negative pregnancy test

- Fertile patients must use effective contraception before, during, and for ? 6 months
after completion of study treatment

- No headaches, disequilibrium, vertigo, or dizziness

- No known history of hepatitis B or C

- No concurrent serious systemic disorder (including active infection) that would
compromise the safety of the patient or compromise the patient's ability to complete
the study, at the discretion of the investigator

- No history of allergic reactions attributed to riluzole

PRIOR CONCURRENT THERAPY:

- No prior WBRT

- At least 2 weeks since prior systemic chemotherapy

- No systemic chemotherapy during and for ? 3 weeks after completion of WBRT

- Radiosurgical boosts to ? 3 metastases allowed, based on the discretion of the
treating radiation oncologist
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01018836      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740